Response to Ipilimumab and Nivolumab in a Patient With Malignant Peritoneal Mesothelioma.

Clin Colorectal Cancer

Department of Medicine, Cedars Cancer Center, McGill University Health Centre (MUHC), Montreal, QC, Canada. Electronic address:

Published: December 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2022.08.001DOI Listing

Publication Analysis

Top Keywords

response ipilimumab
4
ipilimumab nivolumab
4
nivolumab patient
4
patient malignant
4
malignant peritoneal
4
peritoneal mesothelioma
4
response
1
nivolumab
1
patient
1
malignant
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!